MARKET ACCESS
TRACK RECORD
We have an established and proven track record in delivering market access solutions. Our transactions span a variety of product types in a broad range of indications across each stage of the product life cycle.
When working with Staatz, we were able to set up a trial design that would give us the necessary clinical and pharmaco-economic endpoints laying the foundation for a positive outcome in payer negotiations in the major European markets.
When working with Staatz, we were able to set up a trial design that would give us the necessary clinical and pharmaco-economic endpoints laying the foundation for a positive outcome in payer negotiations in the major European markets.
When working with Staatz, we were able to set up a trial design that would give us the necessary clinical and pharmaco-economic endpoints laying the foundation for a positive outcome in payer negotiations in the major European markets.
When working with Staatz, we were able to set up a trial design that would give us the necessary clinical and pharmaco-economic endpoints laying the foundation for a positive outcome in payer negotiations in the major European markets.
For our orphan disease product, the Staatz team consulted and supported us throughout value dossier development and country-specific negotiations. Not only did we obtain targeted reimbursement prices but also gained easily adaptable outputs for further use with our affiliates.”
Working with Staatz Business Development helped shape our processes for market access readiness: with clearly defined responsibilities, to-dos and solutions, we can now follow an approach that is streamlined for both global and affiliate teams.